---
title: How I Manage Acute Respiratory Failure in Patients with Hematological Malignancies
date: '2024-01-17'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38232056/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240118170557&v=2.18.0
source: Blood
description: Acute respiratory failure (ARF) is common in hematological malignancies
  patients, notably those with acute leukemia, myelodysplastic syndrome, or allogeneic
  stem-cell transplantation. ARF is the leading reason for intensive care unit (ICU)
  admission, with a 35% case fatality. Failure to identify the ARF cause is associated
  with mortality. A prompt well-designed diagnostic workup is crucial. The investigations
  are chosen according to pre-test diagnostic probabilities, estimated by the ...
disable_comments: true
---
Acute respiratory failure (ARF) is common in hematological malignancies patients, notably those with acute leukemia, myelodysplastic syndrome, or allogeneic stem-cell transplantation. ARF is the leading reason for intensive care unit (ICU) admission, with a 35% case fatality. Failure to identify the ARF cause is associated with mortality. A prompt well-designed diagnostic workup is crucial. The investigations are chosen according to pre-test diagnostic probabilities, estimated by the ...